Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.65 |
| ▸ | CA2 | P00918 | 2/20 | 0.65 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.61 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.61 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.61 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.61 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.61 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.61 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.61 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.61 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.61 |
| ▸ | PSMA5 | P28066 | 2/20 | 0.61 |
| ▸ | PSMB4 | P28070 | 2/20 | 0.61 |
| ▸ | PSMB6 | P28072 | 2/20 | 0.61 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.61 |
| ▸ | PSMB10 | P40306 | 2/20 | 0.61 |
| ▸ | PSMB3 | P49720 | 2/20 | 0.61 |
| ▸ | PSMB2 | P49721 | 2/20 | 0.61 |
| ▸ | PSMA6 | P60900 | 2/20 | 0.61 |
| ▸ | PSMA8 | Q8TAA3 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11335630 | 0.98 | ENPP2 (0.64) | CA1CA2PSMB11PSMA7PSMB1 | |
| SCHEMBL5537059 | 0.95 | ALDH1A1 (0.64) | CA1CA2PSMB11PSMA7PSMB1 | |
| SCHEMBL9858666 | 0.91 | ENPP2 (0.71) | CA1CA2PSMB11PSMA7PSMB1 | |
| SCHEMBL9510547 | 0.91 | ENPP2 (0.71) | CA1CA2PSMB11PSMA7PSMB1 | |
| SCHEMBL675018 | 0.91 | ENPP2 (0.71) | CA1CA2PSMB11PSMA7PSMB1 | |
| SCHEMBL5542468 | 0.87 | TP53 (0.75) | CA1CA2HPGDNPC1RAB9A | |
| SCHEMBL10782872 | 0.86 | PSMB11 (0.80) | CA1CA2PSMB11PSMA7PSMB1 | |
| SCHEMBL26420478 | 0.86 | HDAC3 (0.75) | CA1CA2PSMB11PSMA7PSMB1 | |
| SCHEMBL7264242 | 0.84 | PSMB11 (0.83) | CA1CA2PSMB11PSMA7PSMB1 | |
| SCHEMBL13510734 | 0.84 | PSMB11 (0.83) | CA1CA2PSMB11PSMA7PSMB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4113495-A | 2,4,4-TRIMETHYL-2-(2,5-DIHYDROXYPHENYL)-6-HYDROXY-CHROMANS | FUJI PHOTO FILM CO., LTD. (JP) | 1978-09-12 | — | — | US | claimed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-1555267-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES | OTSUKA PHARMA CO LTD (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| EP-0778267-A1 | SULFONAMIDE DERIVATIVES AND INSECTICIDE, MITICIDE AND NEMATICIDE CONTAINING THE SAME | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1997-06-11 | — | — | EP | disclosed |
| US-5043460-A | Discoloration inhibition; color photography | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-27 | — | — | US | disclosed |
| US-4745050-A | Silver halide color photographic material and discoloration inhibitor therefor | FUJI PHOTO FILM CO., LTD. (JP) | 1988-05-17 | — | — | US | disclosed |
| US-4367272-A | MORDANTS, REFLECTION | FUJI PHOTO FILM CO., LTD (JP) | 1983-01-04 | — | — | US | disclosed |
| US-4264720-A | CHROMENE COMPOUND COLOR STABILIZING AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1981-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | CA1 3493/4885CA2 1853/4885PSMB11 2367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.